# Diagnostic Role of the "White Test" With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial)

> **NCT04523701** · PHASE3 · RECRUITING · sponsor: **Giulia Manzini** · enrollment: 210 (estimated)

## Conditions studied

- Bile Leakage

## Interventions

- **DRUG:** "white" test" (= the administration of SMOFlipid retrograde through the cystic duct)

## Key facts

- **NCT ID:** NCT04523701
- **Lead sponsor:** Giulia Manzini
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-25
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04523701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04523701, "Diagnostic Role of the "White Test" With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04523701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*